neptcc-bulletin.com | MGH - Neuroendocrine and Pituitary Tumor Clinical Center (NEPTCC)

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Disallow: /wp-admin/ Allow:

Meta Tags

Title	MGH - Neuroendocrine and Pituitary Tumor Clinical Center (NEPTCC)
Description	The Bulletin from the Massachusetts General Hospital (MGH) Neuroendocrine and Pituitary Tumor Clinical Center
Keywords	N/A

Server Information

WebSite	neptcc-bulletin.com
Host IP	35.209.41.74
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

neptcc-bulletin.com Valuation

US$1,005

Last updated: 2023-05-20 07:36:23

neptcc-bulletin.com has Semrush global rank of 0. neptcc-bulletin.com has an estimated worth of US$ 1,005, based on its estimated Ads revenue. neptcc-bulletin.com receives approximately 116 unique visitors each day. Its web server is located in United States, with IP address 35.209.41.74. According to SiteAdvisor, neptcc-bulletin.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$1,005
Daily Ads Revenue	US$0
Monthly Ads Revenue	US$27
Yearly Ads Revenue	US$334
Daily Unique Visitors	7
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
neptcc-bulletin.com.	A	300	IP: 35.209.41.74
neptcc-bulletin.com.	NS	86400	NS Record: ns-1397.awsdns-46.org.
neptcc-bulletin.com.	NS	86400	NS Record: ns-144.awsdns-18.com.
neptcc-bulletin.com.	NS	86400	NS Record: ns-1588.awsdns-06.co.uk.
neptcc-bulletin.com.	NS	86400	NS Record: ns-602.awsdns-11.net.
neptcc-bulletin.com.	MX	300	MX Record: 30 mx-3.pobox.com.
neptcc-bulletin.com.	MX	300	MX Record: 10 mx-1.pobox.com.
neptcc-bulletin.com.	MX	300	MX Record: 20 mx-2.pobox.com.

HtmlToTextCheckTime:2023-05-20 07:36:23

This Issue About Us Prior Issues Contact Neuroendocrine and Pituitary Tumor Clinical Center (NEPTCC) Bulletin Winter 2020/2021 | Volume 26, Issue 1 Journal Club: Review of Levoketoconazole and Osilodrostat in the Treatment of Cushing’s Syndrome ALLISON KIMBALL, MD Cushing’s syndrome is a serious condition characterized by cortisol excess and associated with increased mortality, primarily related to cardiovascular disease (1, 2). The most common source of cortisol overproduction is a pituitary adenoma (Cushing’s disease). Medical treatment is indicated for persistent or recurrent hypercortisolism following surgery, estimated to occur in one third of patients (3), or when surgery or radiation are contraindicated. Although several medications with different mechanisms of action are available, Cushing’s syndrome is difficult to treat. Additional effective and well-tolerated medications are needed. Results from phase 3 trials studying the efficacy and safety of two new pharmacologic

HTTP Headers

HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Mon, 23 Jan 2023 08:54:13 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
Location: https://neptcc-bulletin.com/
Host-Header: 8441280b0c35cbc1147f8ba998a563a7
X-HTTPS-Enforce: 1
X-Proxy-Cache-Info: DT:1

HTTP/2 200 
server: nginx
date: Mon, 23 Jan 2023 08:54:14 GMT
content-type: text/html; charset=UTF-8
vary: Accept-Encoding
expires: Thu, 19 Nov 1981 08:52:00 GMT
cache-control: no-store, no-cache, must-revalidate
pragma: no-cache
x-cache-enabled: True
link: ; rel="https://api.w.org/"
set-cookie: PHPSESSID=5d3b32d72b0a2312cf399d57a373e67e; path=/
x-httpd: 1
host-header: 8441280b0c35cbc1147f8ba998a563a7
x-proxy-cache-info: DT:1

neptcc-bulletin.com valuation and analysis